{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:08:56Z","timestamp":1779289736992,"version":"3.51.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Canadian Institutes of Health Foundation Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-07350-8","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:50:08Z","timestamp":1736178608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Thai Hien","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-3959","authenticated-orcid":false,"given":"Fatima Ezzahra","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser","family":"Masroori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5693-8634","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atena","family":"Nemati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-8949","authenticated-orcid":false,"given":"Nicholas","family":"Rozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amichai Meir","family":"Grunbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Milhalcioiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis-Claude","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-9019","authenticated-orcid":false,"given":"Christopher E.","family":"Rudd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"7350_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","volume":"52","author":"F Amanat","year":"2020","unstructured":"Amanat, F. & Krammer, F. SARS-CoV-2 vaccines: status report. Immunity 52, 583\u2013589 (2020).","journal-title":"Immunity"},{"key":"7350_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., Renia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"7350_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini, F., Chiovato, L., Croce, L., Magri, F. & Rotondi, M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor Rev. 53, 25\u201332 (2020).","journal-title":"Cytokine Growth Factor Rev."},{"key":"7350_CR4","doi-asserted-by":"crossref","unstructured":"Weiskopf D. et al. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci. Immunol. 5, eabd2071 (2020).","DOI":"10.1126\/sciimmunol.abd2071"},{"key":"7350_CR5","unstructured":"Premkumar L. et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol. 5, eabc8413 (2020)."},{"key":"7350_CR6","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang, Y., Yang, C., Xu, X. F., Xu, W. & Liu, S. W. Structural and functional properties of SARS- CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharm. Sin. 41, 1141\u20131149 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"7350_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 183, 1735 (2020).","journal-title":"Cell"},{"key":"7350_CR8","doi-asserted-by":"crossref","unstructured":"Varchetta S., et al. Unique immunological profile in patients with COVID-19. Cell. Mol. Immunol. 18, 604\u2013612 (2020).","DOI":"10.1038\/s41423-020-00557-9"},{"key":"7350_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Reduction and functional exhaustion of t cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020).","journal-title":"Front. Immunol."},{"key":"7350_CR10","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Investig. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Investig."},{"key":"7350_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513 (2020).","journal-title":"Lancet"},{"key":"7350_CR12","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012.e1019 (2020).","journal-title":"Cell"},{"key":"7350_CR13","doi-asserted-by":"crossref","unstructured":"Cizmecioglu, A. et al. Apoptosis-induced T-cell lymphopenia is related to COVID-19 severity. J. Med. Virol. 93, 2867\u20132874 (2020).","DOI":"10.1002\/jmv.26742"},{"key":"7350_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270\u2013274 (2020).","journal-title":"Nature"},{"key":"7350_CR15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T Cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e1415 (2020).","journal-title":"Cell"},{"key":"7350_CR16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4(+) T cells in COVID-19. Cell 183, 1340\u20131353.e1316 (2020).","journal-title":"Cell"},{"key":"7350_CR17","doi-asserted-by":"crossref","unstructured":"Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science 369, eabc8511 (2020).","DOI":"10.1126\/science.369.6508.1203-l"},{"key":"7350_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"JW Song","year":"2020","unstructured":"Song, J. W. et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun. 11, 3410 (2020).","journal-title":"Nat. Commun."},{"key":"7350_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","volume":"5","author":"L Tan","year":"2020","unstructured":"Tan, L. et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct. Target Ther. 5, 33 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"7350_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"7350_CR21","doi-asserted-by":"publisher","first-page":"ofab143","DOI":"10.1093\/ofid\/ofab143","volume":"8","author":"AD Redd","year":"2021","unstructured":"Redd, A. D. et al. CD8+ T-Cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants. Open Forum Infect. Dis. 8, ofab143 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"7350_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s42003-024-05922-2","volume":"7","author":"TH Tu","year":"2024","unstructured":"Tu, T. H. et al. Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity. Commun. Biol. 7, 526 (2024).","journal-title":"Commun. Biol."},{"key":"7350_CR23","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1128\/JVI.02528-08","volume":"83","author":"A Harari","year":"2009","unstructured":"Harari, A., Bellutti Enders, F., Cellerai, C., Bart, P. A. & Pantaleo, G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J. Virol. 83, 2862\u20132871 (2009).","journal-title":"J. Virol."},{"key":"7350_CR24","first-page":"115","volume":"327","author":"J Abbasi","year":"2022","unstructured":"Abbasi, J. COVID-19 vaccine focused on T-cell response promising in early trial. JAMA 327, 115 (2022).","journal-title":"JAMA"},{"key":"7350_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","volume":"26","author":"I Thevarajan","year":"2020","unstructured":"Thevarajan, I. et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat. Med. 26, 453\u2013455 (2020).","journal-title":"Nat. Med."},{"key":"7350_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.immuni.2020.11.016","volume":"53","author":"P Bacher","year":"2020","unstructured":"Bacher, P. et al. Low-avidity CD4(+) T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53, 1258\u20131271.e1255 (2020).","journal-title":"Immunity"},{"key":"7350_CR27","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu, B., Huang, S. & Yin, L. The cytokine storm and COVID-19. J. Med. Virol. 93, 250\u2013256 (2021).","journal-title":"J. Med. Virol."},{"key":"7350_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"7350_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.med.56.082103.104356","volume":"56","author":"TW Rice","year":"2005","unstructured":"Rice, T. W. & Bernard, G. R. Therapeutic intervention and targets for sepsis. Annu Rev. Med 56, 225\u2013248 (2005).","journal-title":"Annu Rev. Med"},{"key":"7350_CR30","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Prim. 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"7350_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.immunol.17.1.435","volume":"17","author":"H Li","year":"1999","unstructured":"Li, H., Llera, A., Malchiodi, E. L. & Mariuzza, R. A. The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 17, 435\u2013466 (1999).","journal-title":"Annu. Rev. Immunol."},{"key":"7350_CR32","doi-asserted-by":"publisher","first-page":"8595","DOI":"10.4049\/jimmunol.177.12.8595","volume":"177","author":"AK Rahman","year":"2006","unstructured":"Rahman, A. K. et al. Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface. J. Immunol. 177, 8595\u20138603 (2006).","journal-title":"J. Immunol."},{"key":"7350_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0952-7915(01)00296-5","volume":"14","author":"EJ Sundberg","year":"2002","unstructured":"Sundberg, E. J., Li, Y. & Mariuzza, R. A. So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes. Curr. Opin. Immunol. 14, 36\u201344 (2002).","journal-title":"Curr. Opin. Immunol."},{"key":"7350_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1146\/annurev.immunol.16.1.523","volume":"16","author":"MM Davis","year":"1998","unstructured":"Davis, M. M. et al. Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 16, 523\u2013544 (1998).","journal-title":"Annu. Rev. Immunol."},{"key":"7350_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.172.3.981","volume":"172","author":"Y Choi","year":"1990","unstructured":"Choi, Y. et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J. Exp. Med. 172, 981\u2013984 (1990).","journal-title":"J. Exp. Med."},{"key":"7350_CR36","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1073\/pnas.86.11.4210","volume":"86","author":"P Scholl","year":"1989","unstructured":"Scholl, P. et al. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc. Natl Acad. Sci. USA 86, 4210\u20134214 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7350_CR37","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/intimm\/9.9.1393","volume":"9","author":"MA Coppola","year":"1997","unstructured":"Coppola, M. A. & Blackman, M. A. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells. Int. Immunol. 9, 1393\u20131403 (1997).","journal-title":"Int. Immunol."},{"key":"7350_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/intimm\/6.7.983","volume":"6","author":"G Biasi","year":"1994","unstructured":"Biasi, G., Panozzo, M., Pertile, P., Mezzalira, S. & Facchinetti, A. Mechanism underlying superantigen-induced clonal deletion of mature T lymphocytes. Int. Immunol. 6, 983\u2013989 (1994).","journal-title":"Int. Immunol."},{"key":"7350_CR39","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.4049\/jimmunol.150.9.3776","volume":"150","author":"T Miethke","year":"1993","unstructured":"Miethke, T., Wahl, C., Heeg, K. & Wagner, H. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity. J. Immunol. 150, 3776\u20133784 (1993).","journal-title":"J. Immunol."},{"key":"7350_CR40","first-page":"1821","volume":"32","author":"J Sicat","year":"2005","unstructured":"Sicat, J., Sutkowski, N. & Huber, B. T. Expression of human endogenous retrovirus HERV-K18 superantigen is elevated in juvenile rheumatoid arthritis. J. Rheumatol. 32, 1821\u20131831 (2005).","journal-title":"J. Rheumatol."},{"key":"7350_CR41","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/art.20021","volume":"50","author":"PA Brogan","year":"2004","unstructured":"Brogan, P. A., Shah, V., Klein, N. & Dillon, M. J. V\u03b2-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum. 50, 589\u2013597 (2004).","journal-title":"Arthritis Rheum."},{"key":"7350_CR42","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1074-7613(01)00211-4","volume":"15","author":"DN Posnett","year":"2001","unstructured":"Posnett, D. N. & Yarilina, A. A. Sleeping with the enemy\u2014 endogenous superantigens in humans. Immunity 15, 503\u2013506 (2001).","journal-title":"Immunity"},{"key":"7350_CR43","doi-asserted-by":"crossref","unstructured":"Porritt, R. A. et al. HLA class I\u2013associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children. J. Clin. Investig. 131, e146614 (2021).","DOI":"10.1172\/JCI146614"},{"key":"7350_CR44","doi-asserted-by":"publisher","first-page":"25254","DOI":"10.1073\/pnas.2010722117","volume":"117","author":"MH Cheng","year":"2020","unstructured":"Cheng, M. H. et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl Acad. Sci. USA 117, 25254\u201325262 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"7350_CR45","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/eji.201646837","volume":"47","author":"D Cibrian","year":"2017","unstructured":"Cibrian, D. & Sanchez-Madrid, F. CD69: from activation marker to metabolic gatekeeper. Eur. J. Immunol. 47, 946\u2013953 (2017).","journal-title":"Eur. J. Immunol."},{"key":"7350_CR46","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nbt.2594","volume":"31","author":"AD Amir el","year":"2013","unstructured":"Amir el, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545\u2013552 (2013).","journal-title":"Nat. Biotechnol."},{"key":"7350_CR47","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jcp.20494","volume":"206","author":"J Bullwinkel","year":"2006","unstructured":"Bullwinkel, J. et al. Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells. J. Cell Physiol. 206, 624\u2013635 (2006).","journal-title":"J. Cell Physiol."},{"key":"7350_CR48","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis, E. J. et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe 27, 992\u20131000.e1003 (2020).","journal-title":"Cell Host Microbe"},{"key":"7350_CR49","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.celrep.2014.07.008","volume":"8","author":"JP Bottcher","year":"2014","unstructured":"Bottcher, J. P. et al. IL-6 trans-signaling-dependent rapid development of cytotoxic CD8+ T cell function. Cell Rep. 8, 1318\u20131327 (2014).","journal-title":"Cell Rep."},{"key":"7350_CR50","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/pro.5560060501","volume":"6","author":"RJ Simpson","year":"1997","unstructured":"Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M. & Ward, L. D. Interleukin-6: structure- function relationships. Protein Sci. 6, 929\u2013955 (1997).","journal-title":"Protein Sci."},{"key":"7350_CR51","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.eclinm.2022.101409","volume":"47","author":"IO Rosas","year":"2022","unstructured":"Rosas, I. O. et al. Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine 47, 101409 (2022).","journal-title":"EClinicalMedicine"},{"key":"7350_CR52","doi-asserted-by":"publisher","first-page":"e1001145","DOI":"10.1371\/journal.pbio.1001145","volume":"9","author":"JD Fraser","year":"2011","unstructured":"Fraser, J. D. Clarifying the mechanism of superantigen toxicity. PLoS Biol. 9, e1001145 (2011).","journal-title":"PLoS Biol."},{"key":"7350_CR53","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","volume":"272","author":"DF Tough","year":"1996","unstructured":"Tough, D. F., Borrow, P. & Sprent, J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947\u20131950 (1996).","journal-title":"Science"},{"key":"7350_CR54","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.3390\/cells11162526","volume":"11","author":"C Amormino","year":"2022","unstructured":"Amormino, C. et al. SARS-CoV-2 spike does not possess intrinsic superantigen-like inflammatory activity. Cells 11, 2526 (2022).","journal-title":"Cells"},{"key":"7350_CR55","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1099\/0022-1317-67-4-719","volume":"67","author":"AJ McMichael","year":"1986","unstructured":"McMichael, A. J., Michie, C. A., Gotch, F. M., Smith, G. L. & Moss, B. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Virol. 67, 719\u2013726 (1986).","journal-title":"J. Gen. Virol."},{"key":"7350_CR56","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1172\/JCI138554","volume":"130","author":"A Mazzoni","year":"2020","unstructured":"Mazzoni, A. et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J. Clin. Investig. 130, 4694\u20134703 (2020).","journal-title":"J. Clin. Investig."},{"key":"7350_CR57","doi-asserted-by":"publisher","first-page":"503","DOI":"10.24272\/j.issn.2095-8137.2020.202","volume":"41","author":"TZ Song","year":"2020","unstructured":"Song, T. Z. et al. Delayed severe cytokine storm and immune cell infiltration in SARS-CoV- 2-infected aged Chinese rhesus macaques. Zool. Res. 41, 503\u2013516 (2020).","journal-title":"Zool. Res."},{"key":"7350_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng, M. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol. Immunol. 17, 533\u2013535 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"7350_CR59","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s42003-019-0442-2","volume":"2","author":"EB Wong","year":"2019","unstructured":"Wong, E. B. et al. TRAV1-2+ CD8+ T-cells including oligoconal expansions of MAIT cells are enriched in the airways in human tuberculosis. Commun. Biol. 2, 203 (2019).","journal-title":"Commun. Biol."},{"key":"7350_CR60","doi-asserted-by":"crossref","unstructured":"Kurcinski, M. et al. CABS-dock standalone: a toolbox for flexible protein\u2013peptide docking. Bioinformatics 35, 4170\u20134172 (2019).","DOI":"10.1093\/bioinformatics\/btz185"},{"key":"7350_CR61","doi-asserted-by":"publisher","first-page":"W443","DOI":"10.1093\/nar\/gky357","volume":"46","author":"P Zhou","year":"2018","unstructured":"Zhou, P., Jin, B., Li, H. & Huang, S. Y. HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm. Nucleic Acids Res. 46, W443\u2013w450 (2018).","journal-title":"Nucleic Acids Res."},{"key":"7350_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1117","volume":"1","author":"M Saline","year":"2010","unstructured":"Saline, M. et al. The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation. Nat. Commun. 1, 119 (2010).","journal-title":"Nat. Commun."},{"key":"7350_CR63","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.4049\/jimmunol.1401268","volume":"193","author":"KEJ R\u00f6dstr\u00f6m","year":"2014","unstructured":"R\u00f6dstr\u00f6m, K. E. J., Elbing, K. & Lindkvist-Petersson, K. Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide\u2013MHC demonstrates absence of TCR\u2013peptide contacts. J. Immunol. 193, 1998 (2014).","journal-title":"J. Immunol."},{"key":"7350_CR64","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.immuni.2009.11.003","volume":"31","author":"OY Borbulevych","year":"2009","unstructured":"Borbulevych, O. Y. et al. T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. Immunity 31, 885\u2013896 (2009).","journal-title":"Immunity"},{"key":"7350_CR65","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/ct500287c","volume":"10","author":"M Kurcinski","year":"2014","unstructured":"Kurcinski, M., Kolinski, A. & Kmiecik, S. Mechanism of folding and binding of an intrinsically disordered protein as revealed by ab initio simulations. J. Chem. Theory Comput. 10, 2224\u20132231 (2014).","journal-title":"J. Chem. Theory Comput."},{"key":"7350_CR66","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1021\/acs.jctc.9b01208","volume":"16","author":"G Weng","year":"2020","unstructured":"Weng, G. et al. Comprehensive evaluation of fourteen docking programs on protein- peptide complexes. J. Chem. Theory Comput 16, 3959\u20133969 (2020).","journal-title":"J. Chem. Theory Comput"},{"key":"7350_CR67","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/jmbi.1999.3091","volume":"292","author":"DT Jones","year":"1999","unstructured":"Jones, D. T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292, 195\u2013202 (1999).","journal-title":"J. Mol. Biol."},{"key":"7350_CR68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"7350_CR69","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1084\/jem.167.5.1697","volume":"167","author":"B Fleischer","year":"1988","unstructured":"Fleischer, B. & Schrezenmeier, H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167, 1697\u20131707 (1988).","journal-title":"J. Exp. Med."},{"key":"7350_CR70","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/imm.12889","volume":"154","author":"KK Jensen","year":"2018","unstructured":"Jensen, K. K. et al. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology 154, 394\u2013406 (2018).","journal-title":"Immunology"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07350-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07350-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:06:29Z","timestamp":1736183189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-07350-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7350"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-07350-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}